See more : Bel Société anonyme (FBEL.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Zepp Health Corporation (ZEPP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zepp Health Corporation, a leading company in the Consumer Electronics industry within the Technology sector.
You may be interested
- Qingdao Daneng Environmental Protection Equipment Co., Ltd. (688501.SS) Income Statement Analysis – Financial Results
- TianYu Eco-Environment Co., Ltd. (603717.SS) Income Statement Analysis – Financial Results
- SanBio Company Limited (SNBIF) Income Statement Analysis – Financial Results
- Yamaha Corporation (7951.T) Income Statement Analysis – Financial Results
- Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) Income Statement Analysis – Financial Results
Zepp Health Corporation (ZEPP)
About Zepp Health Corporation
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.50B | 4.14B | 6.25B | 6.43B | 5.81B | 3.65B | 2.05B | 1.56B | 896.46M |
| Cost of Revenue | 1.84B | 3.34B | 4.94B | 5.10B | 4.34B | 2.71B | 1.55B | 1.28B | 785.87M |
| Gross Profit | 657.78M | 803.12M | 1.31B | 1.33B | 1.47B | 939.45M | 494.70M | 276.15M | 110.59M |
| Gross Profit Ratio | 26.36% | 19.39% | 20.89% | 20.71% | 25.25% | 25.77% | 24.14% | 17.74% | 12.34% |
| Research & Development | 361.81M | 517.12M | 515.08M | 538.01M | 430.82M | 263.22M | 153.83M | 132.30M | 61.55M |
| General & Administrative | 188.51M | 235.93M | 258.35M | 261.81M | 248.46M | 213.97M | 114.88M | 102.64M | 69.98M |
| Selling & Marketing | 314.56M | 460.30M | 438.27M | 358.66M | 181.98M | 96.54M | 44.03M | 27.82M | 19.17M |
| SG&A | 503.07M | 696.24M | 696.62M | 620.46M | 430.44M | 310.51M | 158.91M | 130.47M | 89.15M |
| Other Expenses | 0.00 | 43.82M | 40.93M | -23.55M | 10.59M | 1.18M | 4.56M | 14.73M | 1.11M |
| Operating Expenses | 864.88M | 1.21B | 1.21B | 1.16B | 861.26M | 573.73M | 312.73M | 262.77M | 150.71M |
| Cost & Expenses | 2.70B | 4.55B | 6.16B | 6.26B | 5.21B | 3.28B | 1.87B | 1.54B | 936.57M |
| Interest Income | 3.09M | 12.33M | 16.69M | 46.12M | 33.48M | 11.60M | 3.00M | 754.00K | 255.00K |
| Interest Expense | 6.73M | 57.00M | 44.88M | 22.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 7.68M | 58.62M | 51.88M | 27.13M | 17.22M | 6.22M | 3.72M | 2.40M | 285.00K |
| EBITDA | -134.39M | -354.09M | 93.94M | 105.35M | 623.70M | 357.60M | 185.69M | 15.78M | -39.83M |
| EBITDA Ratio | -5.39% | -8.55% | 2.42% | 1.64% | 10.40% | 9.81% | 8.77% | 1.01% | -4.44% |
| Operating Income | -207.10M | -410.24M | 93.94M | 78.22M | 606.48M | 365.72M | 181.97M | 13.38M | -40.11M |
| Operating Income Ratio | -8.30% | -9.90% | 1.50% | 1.22% | 10.43% | 10.03% | 8.88% | 0.86% | -4.47% |
| Total Other Income/Expenses | 173.70M | 356.25M | -77.21M | -37.57M | -513.25M | -309.52M | -152.58M | 15.48M | 1.36M |
| Income Before Tax | -33.40M | -372.53M | 106.67M | 265.61M | 652.37M | 386.61M | 191.90M | 28.86M | -38.75M |
| Income Before Tax Ratio | -1.34% | -8.99% | 1.71% | 4.13% | 11.22% | 10.61% | 9.37% | 1.85% | -4.32% |
| Income Tax Expense | -2.23M | -65.88M | 10.75M | 31.15M | 77.89M | 52.04M | 27.61M | 3.09M | -897.00K |
| Net Income | -212.12M | -306.66M | 95.92M | 228.75M | 575.20M | 340.05M | 167.68M | 23.95M | -37.85M |
| Net Income Ratio | -8.50% | -7.40% | 1.53% | 3.56% | 9.90% | 9.33% | 8.18% | 1.54% | -4.22% |
| EPS | -13.96 | -4.98 | 1.52 | 3.68 | 9.44 | 6.08 | 0.78 | -0.20 | -0.64 |
| EPS Diluted | -13.96 | -4.98 | 1.45 | 3.51 | 8.99 | 6.04 | 0.78 | -0.20 | -0.64 |
| Weighted Avg Shares Out | 15.20M | 61.57M | 63.04M | 62.12M | 60.91M | 55.94M | 59.43M | 59.43M | 59.43M |
| Weighted Avg Shares Out (Dil) | 15.20M | 61.57M | 66.09M | 65.09M | 63.99M | 56.26M | 59.43M | 59.43M | 59.43M |
Zepp Health Corporation (ZEPP) CEO Huang Wang on Q2 2021 Results - Earnings Call Transcript
Zepp Health Corporation (ZEPP) CEO Huang Wang on Q2 2021 Results - Earnings Call Transcript
Zepp Health Corporation Reports Second Quarter 2021 Unaudited Financial Results
BEIJING, Aug. 19, 2021 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenue of RMB1.8 billion (US$284.2 million), an increase of 61.4% from the same period last year; GAAP diluted net income per share of RMB0.35...
neuro42 Announces the Closing of $6.5M Series A Round
SAN FRANCISCO--(BUSINESS WIRE)--neuro42, the medical technology company leading the next evolution of MRI and robotics, today announced the close of a $6.5M Series A financing round. Zepp Health led the financing round and is joined by ShangBay Capital and prominent...
Zepp Health: Taking Over The Smart Health Wearables Market
Zepp Health: Taking Over The Smart Health Wearables Market
Zepp Health Launches Smart Wearable Chip, Smartwatch OS, Blood Pressure Measurement At Annual Developers Conference
Zepp Health Corp (NYSE: ZEPP) showcased a series of products during its annual developers' conference. It rolled out smart wearable chip Huangshan 2s for its third generation of Amazfit smartwatches.
Listen to Your Body with the Newly-launched Amazfit PowerBuds Pro; TWS Earbuds with Advanced Health Monitoring Features
CUPERTINO, Calif., July 13, 2021 /PRNewswire/ -- Today, Amazfit, a brand of Zepp Health (NYSE: ZEPP), launched the Amazfit PowerBuds Pro - their new true wireless stereo (TWS) earbuds with advanced health monitoring features and powerful multi-scenario active noise cancellation.
Zepp Health Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement at Annual Developers Conference
HEFEI, China, July 13, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) today hosted Next Beat 2021 – The Future of Heath , the company's annual developers conference, which included the announcement of several key company developments. HuangshanTM 2s – Third...
Amazfit's Upcoming Product Will Redefine TWS Earbuds by Bringing Revolutionary Fitness Features
CUPERTINO, Calif., July 9, 2021 /PRNewswire/ -- Amazfit, a brand of Zepp Health (NYSE: ZEPP), is set to launch its new true wireless stereo (TWS) earbuds with health monitoring features.
Zepp Health Corp. Self-Branded Product Line Ranked No. 4 in First Quarter Global Shipment
BEIJING, June 2, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that its Amazfit and Zepp-branded products were among the top four in global shipment for the first...
Zepp Health Corp (ZEPP) CEO Huang Wang on Q1 2021 Results - Earnings Call Transcript
Zepp Health Corp (ZEPP) CEO Huang Wang on Q1 2021 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports
What are the key factors affecting Zepp Health’s financial performance?
A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global …